Clinical trials
Blindness clinical trials
Below are recruiting blindness clinical trials, each written for real people, not researchers. We’re tracking 210 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07732023RecruitingPhase 1
Study of a new asthma medication compared to placebo
This study tests an investigational medication (SKB575) for people with asthma. It aims to see if the drug is safe and works better than a placebo when added to your regular asthma treatments.
Chengdu, SichuanAges 18–70 - NCT07813299Recruiting
Antibiotic rinse in the lungs for bronchiectasis flare-ups
This study tests whether placing a common antibiotic (amikacin) directly into the lungs during a bronchoscopy helps people with bronchiectasis recover faster from sudden flare-ups. Participation involves a bronchoscopy and a lung rinse, which may reduce infection and improve breathing.
Ningbo, ZhejiangAges 18–80 - NCT07813468RecruitingPhase 1
Cetuximab injection study in healthy men
This study tests a new version of the cancer drug cetuximab to see how it compares to the approved version (Erbitux) in healthy men. It helps ensure the new version works the same way in the body.
Haikou, HainanAges 18–46 - NCT07635329Recruiting
Home Vision Therapy Guided by Brain Scans
This study tests whether vision rehabilitation exercises done at home, guided by brain imaging, can help people regain vision after a stroke, brain injury, or tumor. Participants will use brain scans to personalize their therapy.
Washington D.C., District of ColumbiaAges 18 years+ - NCT07621809RecruitingPhase 3
Ianalumab versus placebo for Sjögren's disease with high symptom burden
This study tests whether a new drug called ianalumab can reduce dry mouth and other symptoms in people with Sjögren's disease—a condition where the immune system attacks moisture-producing glands. Participants will receive either ianalumab or a placebo (inactive injection) over 52 weeks to see if the drug helps.
Peoria, ArizonaAges 18 years+ - NCT07827196Recruiting
Brain stimulation for behavior changes in early Alzheimer's
This study tests whether a gentle, non-invasive brain stimulation technique called transcranial random noise stimulation (tRNS) can help reduce troubling behavioral and psychological symptoms (like agitation or anxiety) in people with early Alzheimer's disease. Participants continue their usual medication and receive either real or fake stimulation to see if it improves symptoms.
Hefei, AnhuiAges 45–84 - NCT07699575Recruiting
Can turmeric and ginger help runner recovery?
This trial tests whether taking turmeric, ginger, and black pepper supplements can reduce inflammation and aid recovery in runners completing the 175 km 'Diagonale des Fous' race. It could help you understand natural ways to manage post-race inflammation.
Saint-Pierre, CHU de La RéunionAges 18 years+ - NCT07740824Recruiting
Oral supplement for healthier, younger-looking skin
This study tests an oral supplement to see if it improves signs of facial skin aging in healthy adults. Participants take the supplement daily for 8 weeks and undergo two small skin biopsies on the upper arms to measure changes.
Bangalore, KarnatakaAges 35–65 - NCT07723924RecruitingPhase 2
Plecanatide for constipation in children and teens
This study tests a new medicine called plecanatide for children and teens with functional constipation. It aims to see if it helps improve bowel movements compared to a placebo (a pill with no medicine).
Birmingham, AlabamaAges 6–17 - NCT07755007Recruiting
Blood sample tube transport comparison
This trial compares two ways of sending blood samples from an emergency room to the lab: quickly through a tube system or carried by staff. It checks if either method breaks red blood cells, which can affect test results, to see if the tube system is safe to use.
Istanbul, PendikAges 18 years+ - NCT07523581RecruitingPhase 2
Study of an experimental drug for Alport syndrome
This study tests an experimental medicine for people with Alport syndrome caused by a specific type of gene change (nonsense mutation). The drug may help reduce protein in the urine and slow kidney decline. It is a blinded study, so you won't know if you get the real drug or a placebo.
Los Angeles, CaliforniaAges 12 years+ - NCT07842094Recruiting
Balance and fall prevention training for older adults
This study tests a balance and fall prevention program for older adults living in the community. The program aims to improve stability and reduce fall risk, which may help you feel more confident and steady on your feet.
Hung Hom, KowloonAges 60 years+ - NCT07437911Recruiting
Can a Supplement Help with Nutrient Gaps for GLP-1 Users?
This study tests whether a daily supplement can help fill nutrient gaps and improve gut health for people who are already taking GLP-1 weight-loss medications (like Ozempic or Wegovy). Participants must be on a stable dose for at least 8 weeks and be generally healthy without other chronic conditions.
Santa Monica, CaliforniaAges 18–59 - NCT07611019Enrolling by invitationPhase 2/Phase 3
Colchicine to prevent heart rhythm problems after heart bypass surgery
This study tests whether taking colchicine (a common anti-inflammatory medication) before and after bypass heart surgery can prevent atrial fibrillation—an irregular heartbeat that sometimes occurs after surgery. Researchers hope this simple treatment might reduce complications and improve recovery.
TaipeiAges 20 years+ - NCT07750249Enrolling by invitationEarly Phase 1
Short-chain fatty acids for IgA nephropathy
This trial tests whether a daily supplement of short-chain fatty acids (SCFAs) can slow down kidney damage in people with IgA nephropathy. SCFAs are substances made by gut bacteria that may help reduce inflammation and protect the kidneys.
MartinAges 18 years+ - NCT07529041Enrolling by invitation
Sound cues to help eyes stay still during eye exams
This study tests whether audio feedback (beeping sounds) can help people keep their eyes steady during eye imaging tests. If your eyes move around during exams, this technology might help you stay focused and get better-quality images for diagnosis.
GöttingenAges 18 years+ - NCT07484009Recruiting
ReDS-guided fluid removal for heart failure patients
This trial tests if using a wearable monitor (ReDS) to guide fluid removal helps people hospitalized for heart failure. The goal is to find the right amount of fluid to remove so patients feel better and stay out of the hospital.
Madrid, MadridAges 18 years+ - NCT07473362Recruiting
Oxygen therapy in a high pressure chamber for PTSD
This trial tests whether breathing pure oxygen in a high-pressure chamber can help reduce symptoms of post-traumatic stress disorder (PTSD) in military veterans. It involves 60 daily sessions over 12 weeks, and aims to include both men and women.
Ramat Gan, Tel AvivAges 18–80
Hear when a new Blindness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for blindness?
- Yes. Clin2 currently lists 210 recruiting blindness studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a blindness trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a blindness trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.